The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017

• Ian A. Critchley ,

  Contributed equally to this work with: Ian A. Critchley, Nicole Cotroneo, Michael J. Pucci, Rodrigo Mendes

  Roles Conceptualization, Data curation, Writing – original draft

  * E-mail: icritchley@sperotherapeutics.com

  Affiliation Spero Therapeutics, Cambridge, Massachusetts, United States of America

  http://orcid.org/0000-0003-0981-0758

  ⨯
• Nicole Cotroneo ,

  Contributed equally to this work with: Ian A. Critchley, Nicole Cotroneo, Michael J. Pucci, Rodrigo Mendes

  Roles Conceptualization, Writing – review & editing

  Affiliation Spero Therapeutics, Cambridge, Massachusetts, United States of America

  ⨯
• Michael J. Pucci ,

  Contributed equally to this work with: Ian A. Critchley, Nicole Cotroneo, Michael J. Pucci, Rodrigo Mendes

  Roles Conceptualization, Writing – review & editing

  Affiliation Spero Therapeutics, Cambridge, Massachusetts, United States of America

  ⨯
• Rodrigo Mendes

  Contributed equally to this work with: Ian A. Critchley, Nicole Cotroneo, Michael J. Pucci, Rodrigo Mendes

  Roles Conceptualization, Validation, Writing – original draft, Writing – review & editing

  Affiliation JMI Laboratories, North Liberty, Iowa, United States of America

  ⨯